Navigation Links
Research identifies a way to make cancer cells more responsive to chemotherapy
Date:5/23/2013

Breast cancer characterized as "triple negative" carries a poor prognosis, with limited treatment options. In some cases, chemotherapy doesn't kill the cancer cells the way it's supposed to. New research from Western University explains why some cancer cells don't respond to chemotherapy, and identifies a mechanism to rectify that.

Dr. Shawn Li, PhD, and his team at Western's Schulich School of Medicine & Dentistry, identified that a protein called Numb functions to promote the death of cancer cells by binding to and stabilizing a tumor suppressor protein called p53 -a master regulator of cell death. The scientists found when Numb is reduced or methylated by an enzyme called Set8, it will no longer protect p53. The research is published in the May 23rd issue of Molecular Cell. A related research paper on the role of chemotherapeutic agents on regulating protein methylation, also from the Li lab, will be published in the June 7th issue of Molecular Cell, and is now online.

"If you don't have Numb in a cell, then the p53 can be degraded very quickly, and these cells become resistant to chemotherapy," explains Li, a professor of Biochemistry and Canada Research Chair in Cellular Proteomics and Functional Genomics. "So if we can prevent Numb from being methylated in cancer cells, then we will have the means to sensitize the cell to chemotherapy."

Now that he's identified the Set8-Numb-p53 pathway, Li is investigating various drugs to find a Set8 inhibitor which could be used as a novel breast cancer therapy alone, or in combination with other chemotherapy regiments.


'/>"/>

Contact: Kathy Wallis
kwallis3@uwo.ca
519-661-2111
University of Western Ontario
Source:Eurekalert

Page: 1

Related medicine news :

1. Six Investigators Awarded Lyme Research Alliance Grants
2. Health2Go Announces Research That DHEA Helps Depression
3. Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction
4. Researchers find common childhood asthma unconnected to allergens or inflammation
5. Researchers identify networks of neurons in the brain that are disrupted in psychiatric disease
6. U.S. Specialty Films Market Worth $8 Billion & Packaging Drives Industry by 2017 Says New Research Report at ReportsnReports.com
7. PhD Box Unveils Proposal Writing Services for Research Scholars
8. MarketResearch.com Report – Increased Cost of Albumin was Main Factor for Double-Digit Growth of Global Critical Care Market Between 2006 and 2012
9. HR Strategies Raises Over $6,300 for Cancer Research via Relay For Life
10. Fish Oil Pills Might Cut Diabetes Risk, Researchers Say
11. Alleviating hunger in the US -- researcher says, its a SNAP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... Chicago, IL (PRWEB) , ... July 31, 2015 , ... ... in Boston, when Major League Baseball and the Boston Red Sox honor Ice Bucket ... taking the challenge. MLB is donating $100,000 to further collaborative efforts among the ALS ...
(Date:7/31/2015)... ... July 31, 2015 , ... Successful Import/Export Programs:, Former FDA ... , Having FDA-regulated products held at ports costs time, money and the competitive ... or even destruction — of products, an FDA insider shows manufacturers how to ...
(Date:7/31/2015)... ... July 31, 2015 , ... Burnaby sports physiotherapy clinic, Absolute ... understanding and treatment of ankle sprains. A common sports injury, ankle sprains are ... dangerous if the condition augments and causes more disruption. Absolute PhysioCare’s blog discusses ...
(Date:7/31/2015)... ... July 31, 2015 , ... everMaya ... their latest designer handbag line will be named for Madeline Stuart, an 18-year-old ... the first globally recognized model with Down syndrome, gracing the front pages of ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... as a contributor for LeadingAge’s Center for Aging Services Technologies (CAST) Medication Management ... help long-term and post-acute care providers understand the benefits of using medication ...
Breaking Medicine News(10 mins):Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 2Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 3Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 4Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 2Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 3Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 4Health News:Absolute PhysioCare & Sports Rehab Promotes Understanding & Treatment of Ankle Sprains 2Health News:everMaya to Launch Madeline Stuart Handbag Line 2Health News:everMaya to Launch Madeline Stuart Handbag Line 3Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3
... they become pregnant are at higher risk of having children ... reading tests taken between ages 5 to 7 years - ... suggests. In this large observational study, prepregnancy obesity was ... and a two-point reduction in math scores on a commonly ...
... , TUESDAY, May 8 (HealthDay News) -- The ... bulge has been slow, but certain strategies could speed ... Institute of Medicine (IOM) on Tuesday outlined five recommendations ... recommendations come not a moment too soon: On Monday, ...
... cells have the ability to recycle unwanted or damaged proteins ... have ramped up the system, called autophagy, and rely on ... other treatments. Now, researchers at the Perelman School of Medicine; ... Sciences, at the University of Pennsylvania, have developed a potent ...
... HealthDay Reporter , MONDAY, May 7 (HealthDay News) -- Among ... earlier than thought, a new large survey analysis reveals. ... the last year of high school or college to take ... opioid painkillers, it,ll be a case of too little, too ...
... May 8, 2012 Gene Signal, a company focused ... today announced that positive data from a study of ... of choroidal neovascularization has been presented at the 2012 ... of aganirsen was found to inhibit neovascular growth and ...
... researchers have discovered that a drug already prescribed to ... important use: treating one of the world,s leading causes ... experiments, the scientists found that metformin, which is commonly ... diabetes, also substantially reduced the effects of uveitis, an ...
Cached Medicine News:Health News:Study shows link between pre-pregnancy obesity and lower test scores 2Health News:Study shows link between pre-pregnancy obesity and lower test scores 3Health News:U.S. Report Outlines Strategies to Prevent Obesity 2Health News:Block its recycling system, and cancer kicks the can, according to new Penn study 2Health News:Kids Most Likely to Start Abusing Painkillers at 16: Study 2Health News:Kids Most Likely to Start Abusing Painkillers at 16: Study 3Health News:Gene Signal presents data at ARVO 2012 showing topical aganirsen is active in retinal disease 2Health News:Diabetes drug could treat leading cause of blindness 2
(Date:7/31/2015)... , July 31, 2015 Egalet Corporation ... specialty pharmaceutical company focused on developing, manufacturing and ... of its previously announced underwritten public offering of ... public offering price of $11.25 per share. The ... 1,000,000 shares issued upon the exercise in full ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015 /PRNewswire/ ... Co., Ltd. (Headquarters: Tokyo , President ... Therapeutics, Inc. (Headquarters: San Diego, California ... "NASDAQ: HALO") have signed a clinical collaboration agreement to ... "eribulin") in combination with Halozyme,s investigational drug PEGPH20 (PEGylated ...
(Date:7/31/2015)... According to a new market ... Analyzers (BIA), Dual-Energy X-ray Absorptiometry (DEXA), Skinfold Calipers, Air ... & Forecast to 2019", published by MarketsandMarkets, the global ... 2014 and is estimated to grow to $1,425.7 Million ... 2014 to 2019. Browse 41 market ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4
... Questcor Pharmaceuticals, Inc . (Nasdaq: QCOR ) today announced that it ... FDA Panel meeting on Monday, May 10, 2010 at ... . Don Bailey , President and Chief Executive Officer; Steve ... , Chief Science Officer; and Dr. Jason Zielonka , Senior Vice President ...
... , May 3 Watson Pharmaceuticals, Inc. (NYSE: WPI ... Watson,s president and chief executive officer, will provide an overview and update of ... Tuesday, May 11, 2010 at 1:40pm Eastern Daylight Time ... , , ...
Cached Medicine Technology:Questcor to Discuss Results From FDA Panel Meeting 2Watson To Present at Bank Of America/Merrill Lynch 2010 Healthcare Conference 2
The Multiple Perfusion set provides simultaneous perfusion of the aortic root and up to three or more vein grafts. The set features an inlet port with female luer and clamp attached to an adapter whi...
The Aortic Root Cannulae With Vent Line are flanged, with radiopaque tips; two side holes in tip....
The KAVD Venous Cannula is the first of its kind. It is a combination of cannulae/venous line designed to "bridge the gap between the patient and the Medtronic Resting Heart System circuit....
... Medtronic Select CAP® cannulae provides a ... pressure readings. An innovative combination of ... monitoring line, the Select CAP® can ... central arterial pressure readings on which ...
Medicine Products: